Leber Congenital Amaurosis

8 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Retinal Diseases

Treatments and conditions

Leber Congenital Amaurosis
Treatment and conditionWhere it standsTrials
AAV2-hRPE65v2,voretigene neparvovec-rzyl for leber congenital amaurosisTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Brinretigene Vesgedparvovec for leber congenital amaurosisPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
OCU400 High Dose for leber congenital amaurosisPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
OCU400 High Dose + OCU400 Med Dose for leber congenital amaurosisPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
OCU400 Low Dose for leber congenital amaurosisPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
OCU400 Med Dose for leber congenital amaurosisPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
OCU400 Second Eye Dosing for leber congenital amaurosisPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
voretigene neparvovec-rzyl for leber congenital amaurosisPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)2

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.